Skip to main content
. 2022 Nov 28;12(12):1773. doi: 10.3390/biom12121773

Figure 5.

Figure 5

Cardiomyocytes morphometric analysis. (A) Cardiomyocytes irregularity index (CII); (B) variability of cardiomyocyte area. Data expressed as median (25th–75th percentile), Kruskal–Wallis test. Different letters indicate a significant difference between groups (p < 0.05). LOLA: ornithine aspartate; NAFLD: nonalcoholic fatty liver disease, and VitE: vitamin E.